Boston Scientific’s Recent Acquisitions and What They Mean
In April, Boston Scientific (BSX) closed two acquisitions: NxThera and nVision Medical. The NxThera closing was on April 30. NxThera developed the Rezūm System, which is a minimally invasive therapy in a growing category of treatment options for patients with benign prostatic hyperplasia (or BPH). Boston Scientific already had a minority stake in NxThera.